Cross-institution positioning
May 6, 2026Broad reduction. 2 reducing across 2 comparable institutions.
Source: Schedule 13 researchBIO-TECHNE Corp
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
A compact read across the newest available filing, institutional, insider, company-event, 13F, fundamental, and price evidence. Each item keeps its own reporting window; the evidence is not collapsed into a buy or sell recommendation.
Broad reduction. 2 reducing across 2 comparable institutions.
Source: Schedule 13 researchRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Recent close is 100% through its reported 52-week range; +36.8% over one year.
Source: Stored historical price seriesWhen mapped Schedule 13 evidence is available, Investor and Pro connect the filing to prior ownership, timing, price context, and significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Hippel James | MExercise or conversion of derivative · derivative | Stock Options (Right to Buy) | 62.1K | $0.00 | Direct | Jul 31, 2026 |
| Jul 29, 2026 | Hippel James | FTax/price withholding or payment | Common Stock | 51.0K | $72.03 | Direct | Jul 31, 2026 |
| Jul 29, 2026 | Hippel James | MExercise or conversion of derivative | Common Stock | 62.1K | $47.60 | Direct | Jul 31, 2026 |
| Jul 28, 2026 | Kelderman Kim | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 35.0K | $0.00 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Kelderman Kim | FTax/price withholding or payment | Common Stock | 28.7K | $72.07 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Kelderman Kim | MExercise or conversion of derivative | Common Stock | 35.0K | $47.60 | Direct | Jul 30, 2026 |
| Jul 23, 2026 | Bohnen Shane | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 448 | $0.00 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Bohnen Shane | FTax/price withholding or payment | Common Stock | 344 | $71.77 | Direct | Jul 27, 2026 |
| Jul 23, 2026 | Bohnen Shane | MExercise or conversion of derivative | Common Stock | 448 | $47.60 | Direct | Jul 27, 2026 |
| Jun 2, 2026 | Crouse Steven C. | MExercise or conversion of derivative · derivative | Restricted Stock Units | 600 | $0.00 | Direct | Jun 4, 2026 |
| Jun 2, 2026 | Crouse Steven C. | FTax/price withholding or payment | Common Stock | 216 | $49.77 | Direct | Jun 4, 2026 |
| Jun 2, 2026 | Crouse Steven C. | MExercise or conversion of derivative | Common Stock | 600 | — | Direct | Jun 4, 2026 |
| May 8, 2026 | Herr Amy E. | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 6.6K | $0.00 | Indirect | May 12, 2026 |
| May 8, 2026 | Herr Amy E. | SOpen-market or private sale | Common Stock | 6.6K | $48.28 | Indirect | May 12, 2026 |
| May 8, 2026 | Herr Amy E. | MExercise or conversion of derivative | Common Stock | 6.6K | $47.60 | Indirect | May 12, 2026 |
| May 5, 2026 | Hippel James | MExercise or conversion of derivative · derivative | Stock Options (Right to Buy) | 62.0K | $0.00 | Direct | May 7, 2026 |
| May 5, 2026 | Hippel James | FTax/price withholding or payment | Common Stock | 57.0K | $56.68 | Direct | May 7, 2026 |
| May 5, 2026 | Hippel James | MExercise or conversion of derivative | Common Stock | 62.0K | $47.60 | Direct | May 7, 2026 |
| May 5, 2026 | Bohnen Shane | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 8.4K | $0.00 | Direct | May 7, 2026 |
| May 5, 2026 | Bohnen Shane | FTax/price withholding or payment | Common Stock | 7.1K | $56.68 | Direct | May 7, 2026 |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|
Compare TECH with other securities showing similar institutional activity or recent accumulation across several tracked institutions.